特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
691698

消化性潰瘍治療薬の世界市場:成長動向と競合分析:2018年~2025年

Global Peptic Ulcer Drugs Industry Research Report, Growth Trends and Competitive Analysis 2018-2025

出版日: | 発行: QYResearch | ページ情報: 英文 118 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.81円
消化性潰瘍治療薬の世界市場:成長動向と競合分析:2018年~2025年
出版日: 2018年09月04日
発行: QYResearch
ページ情報: 英文 118 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界の消化性潰瘍治療薬市場を調査し、市場の概要、タイプ・用途・地域別の市場動向、売上数・収益額の推移と予測(過去5年、今後8年間分)、市場シェア、市場の成長要因、主要企業のプロファイルなど、包括的な情報を提供しています。

第1章 市場概要

  • 調査範囲
  • 調査対象の製薬企業
  • 市場区分:タイプ別
    • プロトンポンプ阻害薬(PPI)
    • カリウムイオン競合型アシッドブロッカー(P-CAB)
    • 制酸薬
    • ヒスタミンH2受容体拮抗薬
    • 抗生物質
    • 胃粘膜保護薬
  • 市場区分:用途別
    • 病院
    • 外来ケア
    • その他
  • 調査目的
  • 調査期間

第2章 成長動向

  • 市場規模
    • 収益額
    • 売上数
  • 地域別の成長率
  • 産業動向
    • 主な市場動向
    • 市場促進要因

第3章 市場シェア:企業別

  • 消化性潰瘍治療薬の売上数:企業別
    • 売上数の推移
    • 売上シェア
  • 消化性潰瘍治療薬の収益額:企業別
    • 収益額の推移
    • 収益シェア
    • 企業の市場集中度
  • 医薬品価格:企業別
  • 主要企業の生産拠点・工場の分布
  • 主要企業の市場参入時期
  • 主要企業の製品
  • 合併・買収・事業拡大計画

第4章 市場規模:タイプ別

  • 売上数と収益額の推移
    • プロトンポンプ阻害薬(PPI)
    • カリウムイオン競合型アシッドブロッカー(P-CAB)
    • 制酸薬
  • 売上シェア:タイプ別
  • 収益シェア:タイプ別
  • 価格:タイプ別

第5章 市場規模:用途別

  • 市場概要
  • 売上数:用途別

第6章 北米の消化性潰瘍治療薬市場

  • 市場内訳:企業別
  • 市場内訳:タイプ別
  • 市場内訳:用途別
  • 市場内訳:国別
    • 米国
    • カナダ
    • メキシコ

第7章 欧州の消化性潰瘍治療薬市場

  • 市場内訳:企業別
  • 市場内訳:タイプ別
  • 市場内訳:用途別
  • 市場内訳:国別
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア

第8章 アジア太平洋の消化性潰瘍治療薬市場

  • 市場内訳:企業別
  • 市場内訳:タイプ別
  • 市場内訳:用途別
  • 市場内訳:国別
    • 中国
    • 日本
    • 韓国
    • インド
    • オーストラリア
    • インドネシア
    • マレーシア
    • フィリピン
    • タイ
    • ベトナム

第9章 中南米の消化性潰瘍治療薬市場

  • 市場内訳:企業別
  • 市場内訳:タイプ別
  • 市場内訳:用途別
  • 市場内訳:国別
    • ブラジル

第10章 中東・アフリカの消化性潰瘍治療薬市場

  • 市場内訳:企業別
  • 市場内訳:タイプ別
  • 市場内訳:用途別
  • 市場内訳:地域/国別
    • 湾岸協力会議(GCC)
    • エジプト
    • 南アフリカ

第11章 企業プロファイル

  • Daewoong Pharmaceutical
  • 武田薬品工業
  • Pfizer
  • Abbott Laboratories
  • AstraZeneca
  • Cadila Healthcare
  • Boehringer Ingelheim
  • エーザイ
  • Yuhan
  • GlaxoSmithKline Pharmaceuticals

第12章 バリューチェーンと販売チャネルの分析

  • バリューチェーン分析
  • 販売チャネル分析
    • 販売チャネル
    • 流通業者
  • 顧客

第13章 市場予測

  • 売上数と収益額の予測
  • 売上数の予測:タイプ別
  • 売上数の予測:用途別
  • 市場予測:地域別
  • 北米
  • 欧州
  • アジア太平洋
  • 中南米
  • 中東・アフリカ

第14 調査結果と総論

第15章 付録

図表

List of Tables and Figures

  • Figure Peptic Ulcer Drugs Product Picture
  • Table Peptic Ulcer Drugs Key Market Segments
  • Table Major Manufacturers Peptic Ulcer Drugs Covered in This Report
  • Table Global Peptic Ulcer Drugs Market Size Growth Rate by Type 2018-2025 (K Units) & (Million US$)
  • Figure Global Peptic Ulcer Drugs Sales Market Shar by Type 2013-2025
  • Figure Proton Pump Inhibitors Figures
  • Table Major Manufacturers of Proton Pump Inhibitors
  • Figure Potassium-Competitive Acid Blockers Figures
  • Table Major Manufacturers of Potassium-Competitive Acid Blockers
  • Figure Antacids Figures
  • Table Major Manufacturers of Antacids
  • Figure H2-Antagonists Figures
  • Table Major Manufacturers of H2-Antagonists
  • Figure Antibiotics Figures
  • Table Global Peptic Ulcer Drugs Market Share by Application 2018-2025 (K Units)
  • Figure Hospital Pharmacies Use Case
  • Figure Private Clinics Use Case
  • Figure Peptic Ulcer Drugs Report Years Considered
  • Figure Global Peptic Ulcer Drugs Market Size 2013-2025 (Million US$)
  • Figure Global Peptic Ulcer Drugs Sales 2013-2018 (K Units)
  • Table Global Peptic Ulcer Drugs Market Size by Regions 2013-2018 (K Units) & (Million US$)
  • Table Global Peptic Ulcer Drugs Sales by Regions 2013-2018 (K Units)
  • Table Global Peptic Ulcer Drugs Sales Market Share by Regions 2013-2018
  • Figure Global Peptic Ulcer Drugs Sales Market Share by Regions 2013-2018
  • Figure Global Peptic Ulcer Drugs Sales Market Share by Regions in 2018
  • Table Global Peptic Ulcer Drugs Revenue by Regions 2013-2018 (Million US$)
  • Table Global Peptic Ulcer Drugs Revenue Market Share by Regions 2013-2018
  • Figure Global Peptic Ulcer Drugs Revenue Market Share by Regions 2013-2018
  • Figure Global Peptic Ulcer Drugs Revenue Market Share by Regions in 2018
  • Table Market Top Trends
  • Table Global Peptic Ulcer Drugs Sales by Manufacturers (2013-2018) (K Units)
  • Table Global Peptic Ulcer Drugs Sales Share by Manufacturers (2013-2018)
  • Figure Global Peptic Ulcer Drugs Sales Share by Manufacturers in 2018
  • Table Peptic Ulcer Drugs Revenue by Manufacturers (2013-2018) (Million USD)
  • Table Peptic Ulcer Drugs Revenue Share by Manufacturers (2013-2018)
  • Figure Peptic Ulcer Drugs Value Share by Manufacturers in 2018
  • Table Global Peptic Ulcer Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table Key Manufacturers Peptic Ulcer Drugs Price (2013-2018) (USD/Unit)
  • Table Key Manufacturers Peptic Ulcer Drugs Plants/Factories Distribution
  • Table Key Manufacturers Peptic Ulcer Drugs Area Served
  • Table Date of Key Manufacturers Enter into Peptic Ulcer Drugs Market
  • Table Key Manufacturers Peptic Ulcer Drugs Product Type
  • Table Mergers & Acquisitions, Expansion Plans
  • Table Global Proton Pump Inhibitors Sales and Revenue (2013-2018) (K Units) & (Million US$)
  • Table Global Potassium-Competitive Acid Blockers Sales and Revenue (2013-2018) (K Units) & (Million US$)
  • Table Global Antacids Sales and Revenue (2013-2018) (K Units) & (Million US$)
  • Table Global Peptic Ulcer Drugs Sales by Type (2013-2018) (K Units)
  • Table Global Peptic Ulcer Drugs Sales Share by Type (2013-2018)
  • Figure Global Peptic Ulcer Drugs Sales Market Share by Type (2013-2018)
  • Figure Global Peptic Ulcer Drugs Sales Market Share by Type in 2017
  • Table Global Peptic Ulcer Drugs Revenue by Type (2013-2018) (Million US$)
  • Table Global Peptic Ulcer Drugs Revenue Share by Type (2013-2018)
  • Figure Global Peptic Ulcer Drugs Revenue Market Share by Type (2013-2018)
  • Figure Global Peptic Ulcer Drugs Revenue Market Share by Type in 2017
  • Table Peptic Ulcer Drugs Price by Type 2013-2018 (USD/Unit)
  • Table Global Peptic Ulcer Drugs Sales by Application (2013-2018) (K Units)
  • Table Global Peptic Ulcer Drugs Sales Share by Application (2013-2018)
  • Figure Global Sales Peptic Ulcer Drugs Market Share by Application (2013-2018)
  • Figure Global Sales Peptic Ulcer Drugs Market Share by Application in 2017
  • Figure North America Peptic Ulcer Drugs Sales Growth Rate 2013-2018 (K Units)
  • Figure North America Peptic Ulcer Drugs Revenue Growth Rate 2013-2018 (Million US$)
  • Table North America Peptic Ulcer Drugs Sales by Company (2013-2018) (K Units)
  • Table North America Peptic Ulcer Drugs Sales Market Share by Company (2013-2018)
  • Figure North America Peptic Ulcer Drugs Sales Market Share by Company in 2018
  • Table North America Peptic Ulcer Drugs Sales by Type (2013-2018) (K Units)
  • Table North America Peptic Ulcer Drugs Sales Market Share by Type (2013-2018)
  • Figure North America Peptic Ulcer Drugs Market Share by Type in 2018
  • Table North America Peptic Ulcer Drugs Sales by Application (2013-2018) (K Units)
  • Table North America Peptic Ulcer Drugs Sales Market Share by Application (2013-2018)
  • Figure North America Peptic Ulcer Drugs Market Share by Application in 2018
  • Table North America Peptic Ulcer Drugs Sales by Countries (2013-2018) (K Units)
  • Table North America Peptic Ulcer Drugs Sales Market Share by Countries (2013-2018)
  • Figure 2017 North America Peptic Ulcer Drugs Sales Market Share by Countries
  • Table North America Peptic Ulcer Drugs Revenue by Countries (2013-2018) (Million US$)
  • Table North America Peptic Ulcer Drugs Revenue Market Share by Countries (2013-2018)
  • Figure 2017 North America Peptic Ulcer Drugs Revenue Market Share by Countries
  • Figure United States Peptic Ulcer Drugs Sales Growth Rate (2013-2018) (K Units)
  • Figure Canada Peptic Ulcer Drugs Sales Growth Rate (2013-2018) (K Units)
  • Figure Mexico Peptic Ulcer Drugs Sales Growth Rate (2013-2018) (K Units)
  • Figure Europe Peptic Ulcer Drugs Sales Growth Rate 2013-2018 (K Units)
  • Figure Europe Peptic Ulcer Drugs Revenue Growth Rate 2013-2018 (Million US$)
  • Table Europe Peptic Ulcer Drugs Sales by Company (2013-2018) (K Units)
  • Table Europe Peptic Ulcer Drugs Sales Market Share by Company (2013-2018)
  • Figure Europe Peptic Ulcer Drugs Sales Market Share by Company in 2018
  • Table Europe Peptic Ulcer Drugs Sales by Type (2013-2018) (K Units)
  • Table Europe Peptic Ulcer Drugs Sales Market Share by Type (2013-2018)
  • Figure 2017 Europe Peptic Ulcer Drugs Market Share by Type
  • Table Europe Peptic Ulcer Drugs Sales by Application (2013-2018) (K Units)
  • Table Europe Peptic Ulcer Drugs Sales Market Share by Application (2013-2018)
  • Figure 2017 Europe Peptic Ulcer Drugs Market Share by Application
  • Table Europe Peptic Ulcer Drugs Sales by Countries (2013-2018) (K Units)
  • Table Europe Peptic Ulcer Drugs Sales Market Share by Countries (2013-2018)
  • Figure 2017 Europe Peptic Ulcer Drugs Sales Market Share by Countries
  • Table Europe Peptic Ulcer Drugs Revenue by Countries (2013-2018) (Million US$)
  • Table Europe Peptic Ulcer Drugs Revenue Market Share by Countries (2013-2018)
  • Figure Europe Peptic Ulcer Drugs Revenue Market Share by Countries in 2018
  • Figure Germany Peptic Ulcer Drugs Sales Growth Rate (2013-2018) (K Units)
  • Figure France Peptic Ulcer Drugs Sales Growth Rate (2013-2018) (K Units)
  • Figure UK Peptic Ulcer Drugs Sales Growth Rate (2013-2018) (K Units)
  • Figure Italy Peptic Ulcer Drugs Sales Growth Rate (2013-2018) (K Units)
  • Figure Russia Peptic Ulcer Drugs Sales Growth Rate (2013-2018) (K Units)
  • Figure Asia Pacific Peptic Ulcer Drugs Sales Growth Rate 2013-2018 (K Units)
  • Figure Asia Pacific Peptic Ulcer Drugs Revenue Growth Rate 2013-2018 (Million US$)
  • Table Asia Pacific Peptic Ulcer Drugs Sales by Company (2013-2018) (K Units)
  • Table Asia Pacific Peptic Ulcer Drugs Sales Market Share by Company (2013-2018)
  • Figure Asia Pacific Peptic Ulcer Drugs Sales Market Share by Company in 2018
  • Table Asia Pacific Peptic Ulcer Drugs Sales by Type (2013-2018) (K Units)
  • Table Asia Pacific Peptic Ulcer Drugs Sales Market Share by Type (2013-2018)
  • Figure Asia Pacific Peptic Ulcer Drugs Market Share by Type in 2018
  • Table Asia Pacific Peptic Ulcer Drugs Sales by Application (2013-2018) (K Units)
  • Table Asia Pacific Peptic Ulcer Drugs Sales Market Share by Application (2013-2018)
  • Figure Asia Pacific Peptic Ulcer Drugs Market Share by Application in 2018
  • Table Asia Pacific Peptic Ulcer Drugs Sales by Countries (2013-2018) (K Units)
  • Table Asia Pacific Peptic Ulcer Drugs Sales Market Share by Countries (2013-2018)
  • Figure 2017 Asia Pacific Peptic Ulcer Drugs Sales Market Share by Countries
  • Table Asia Pacific Peptic Ulcer Drugs Revenue by Countries (2013-2018) (Million US$)
  • Table Asia Pacific Peptic Ulcer Drugs Revenue Market Share by Countries (2013-2018)
  • Figure 2017 Asia Pacific Peptic Ulcer Drugs Revenue Market Share by Countries
  • Figure China Peptic Ulcer Drugs Sales Growth Rate (2013-2018) (K Units)
  • Figure China Peptic Ulcer Drugs Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Japan Peptic Ulcer Drugs Sales Growth Rate (2013-2018) (K Units)
  • Figure Japan Peptic Ulcer Drugs Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Korea Peptic Ulcer Drugs Sales Growth Rate (2013-2018) (K Units)
  • Figure Korea Peptic Ulcer Drugs Revenue Growth Rate (2013-2018) (Million US$)
  • Figure India Peptic Ulcer Drugs Sales Growth Rate (2013-2018) (K Units)
  • Figure India Peptic Ulcer Drugs Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Australia Peptic Ulcer Drugs Sales Growth Rate (2013-2018) (K Units)
  • Figure Australia Peptic Ulcer Drugs Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Indonesia Peptic Ulcer Drugs Sales Growth Rate (2013-2018) (K Units)
  • Figure Indonesia Peptic Ulcer Drugs Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Malaysia Peptic Ulcer Drugs Sales Growth Rate (2013-2018) (K Units)
  • Figure Malaysia Peptic Ulcer Drugs Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Philippines Peptic Ulcer Drugs Sales Growth Rate (2013-2018) (K Units)
  • Figure Philippines Peptic Ulcer Drugs Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Thailand Peptic Ulcer Drugs Sales Growth Rate (2013-2018) (K Units)
  • Figure Thailand Peptic Ulcer Drugs Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Vietnam Peptic Ulcer Drugs Sales Growth Rate (2013-2018) (K Units)
  • Figure Vietnam Peptic Ulcer Drugs Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Central & South America Peptic Ulcer Drugs Sales Growth Rate 2013-2018 (K Units)
  • Figure Central & South America Peptic Ulcer Drugs Revenue Growth Rate 2013-2018 (Million US$)
  • Table Central & South America Peptic Ulcer Drugs Sales by Company (2013-2018) (K Units)
  • Table Central & South America Peptic Ulcer Drugs Sales Market Share by Company (2013-2018)
  • Figure Central & South America Peptic Ulcer Drugs Sales Market Share by Company in 2018
  • Table Central & South America Peptic Ulcer Drugs Sales by Type (2013-2018) (K Units)
  • Table Central & South America Peptic Ulcer Drugs Sales Market Share by Type (2013-2018)
  • Figure Central & South America Peptic Ulcer Drugs Market Share by Type in 2018
  • Table Central & South America Peptic Ulcer Drugs Sales by Application (2013-2018) (K Units)
  • Table Central & South America Peptic Ulcer Drugs Sales Market Share by Application (2013-2018)
  • Figure Central & South America Peptic Ulcer Drugs Market Share by Application in 2018
  • Table Central & South America Peptic Ulcer Drugs Sales by Countries (2013-2018) (K Units)
  • Table Central & South America Peptic Ulcer Drugs Sales Market Share by Countries (2013-2018)
  • Figure Central & South America Peptic Ulcer Drugs Sales Market Share by Countries in 2018
  • Table Central & South America Peptic Ulcer Drugs Revenue by Countries (2013-2018) (Million US$)
  • Table Central & South America Peptic Ulcer Drugs Revenue Market Share by Countries (2013-2018)
  • Figure Central & South America Peptic Ulcer Drugs Revenue Market Share by Countries in 2018
  • Figure Brazil Peptic Ulcer Drugs Sales Growth Rate (2013-2018) (K Units)
  • Figure Brazil Peptic Ulcer Drugs Revenue Growth Rate (2013-2018) (K Units)
  • Figure Middle East and Africa Peptic Ulcer Drugs Sales Growth Rate 2013-2018 (K Units)
  • Figure Middle East and Africa Peptic Ulcer Drugs Revenue Growth Rate 2013-2018 (Million US$)
  • Table Middle East and Africa Peptic Ulcer Drugs Sales by Type (2013-2018) (K Units)
  • Table Middle East and Africa Peptic Ulcer Drugs Sales Market Share by Type (2013-2018)
  • Figure 2017 Middle East and Africa Peptic Ulcer Drugs Market Share by Type
  • Table Middle East and Africa Peptic Ulcer Drugs Sales by Application (2013-2018) (K Units)
  • Table Middle East and Africa Peptic Ulcer Drugs Sales Market Share by Application (2013-2018)
  • Figure 2017 Middle East and Africa Peptic Ulcer Drugs Market Share by Application
  • Table Middle East and Africa Peptic Ulcer Drugs Sales by Countries (2013-2018) (K Units)
  • Table Middle East and Africa Peptic Ulcer Drugs Sales Market Share by Countries (2013-2018)
  • Figure 2017 Middle East and Africa Peptic Ulcer Drugs Sales Market Share by Countries
  • Table Middle East and Africa Peptic Ulcer Drugs Revenue by Countries (2013-2018) (Million US$)
  • Table Middle East and Africa Peptic Ulcer Drugs Revenue Market Share by Countries (2013-2018)
  • Figure 2017 Middle East and Africa Peptic Ulcer Drugs Revenue Market Share by Countries
  • Figure GCC Countries Peptic Ulcer Drugs Sales Growth Rate (2013-2018) (K Units)
  • Figure GCC Countries Peptic Ulcer Drugs Revenue Growth Rate (2013-2018) (K Units)
  • Figure Egypt Peptic Ulcer Drugs Sales Growth Rate (2013-2018) (K Units)
  • Figure Egypt Peptic Ulcer Drugs Revenue Growth Rate (2013-2018) (K Units)
  • Figure South Africa Peptic Ulcer Drugs Sales Growth Rate (2013-2018) (K Units)
  • Figure South Africa Peptic Ulcer Drugs Revenue Growth Rate (2013-2018) (K Units)
  • Table Daewoong Pharmaceutical Company Details
  • Table Daewoong Pharmaceutical Description and Business Overview
  • Table Daewoong Pharmaceutical Peptic Ulcer Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table Daewoong Pharmaceutical Peptic Ulcer Drugs Sales Growth Rate (2013-2018)
  • Table Daewoong Pharmaceutical Peptic Ulcer Drugs Sales Market Share in Global Market
  • Table Daewoong Pharmaceutical Recent Development
  • Table Takeda Pharmaceutical Company Details
  • Table Takeda Pharmaceutical Description and Business Overview
  • Table Takeda Pharmaceutical Peptic Ulcer Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table Takeda Pharmaceutical Peptic Ulcer Drugs Sales Growth Rate (2013-2018)
  • Table Takeda Pharmaceutical Peptic Ulcer Drugs Sales Market Share in Global Market
  • Table Takeda Pharmaceutical Recent Development
  • Table Pfizer Company Details
  • Table Pfizer Description and Business Overview
  • Table Pfizer Peptic Ulcer Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table Pfizer Peptic Ulcer Drugs Sales Growth Rate (2013-2018)
  • Table Pfizer Peptic Ulcer Drugs Sales Market Share in Global Market
  • Table Pfizer Recent Development
  • Table Abbott Laboratories Company Details
  • Table Abbott Laboratories Description and Business Overview
  • Table Abbott Laboratories Peptic Ulcer Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table Abbott Laboratories Peptic Ulcer Drugs Sales Growth Rate (2013-2018)
  • Table Abbott Laboratories Peptic Ulcer Drugs Sales Market Share in Global Market
  • Table Abbott Laboratories Recent Development
  • Table AstraZeneca Company Details
  • Table AstraZeneca Description and Business Overview
  • Table AstraZeneca Peptic Ulcer Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table AstraZeneca Peptic Ulcer Drugs Sales Growth Rate (2013-2018)
  • Table AstraZeneca Peptic Ulcer Drugs Sales Market Share in Global Market
  • Table AstraZeneca Recent Development
  • Table Cadila Healthcare Company Details
  • Table Cadila Healthcare Description and Business Overview
  • Table Cadila Healthcare Peptic Ulcer Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table Cadila Healthcare Peptic Ulcer Drugs Sales Growth Rate (2013-2018)
  • Table Cadila Healthcare Peptic Ulcer Drugs Sales Market Share in Global Market
  • Table Cadila Healthcare Recent Development
  • Table Boehringer Ingelheim Company Details
  • Table Boehringer Ingelheim Description and Business Overview
  • Table Boehringer Ingelheim Peptic Ulcer Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table Boehringer Ingelheim Peptic Ulcer Drugs Sales Growth Rate (2013-2018)
  • Table Boehringer Ingelheim Peptic Ulcer Drugs Sales Market Share in Global Market
  • Table Boehringer Ingelheim Recent Development
  • Table Eisai Company Details
  • Table Eisai Description and Business Overview
  • Table Eisai Peptic Ulcer Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table Eisai Peptic Ulcer Drugs Sales Growth Rate (2013-2018)
  • Table Eisai Peptic Ulcer Drugs Sales Market Share in Global Market
  • Table Eisai Recent Development
  • Table Yuhan Company Details
  • Table Yuhan Description and Business Overview
  • Table Yuhan Peptic Ulcer Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table Yuhan Peptic Ulcer Drugs Sales Growth Rate (2013-2018)
  • Table Yuhan Peptic Ulcer Drugs Sales Market Share in Global Market
  • Table Yuhan Recent Development
  • Table GlaxoSmithKline Pharmaceuticals Company Details
  • Table GlaxoSmithKline Pharmaceuticals Description and Business Overview
  • Table GlaxoSmithKline Pharmaceuticals Peptic Ulcer Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
  • Figure Peptic Ulcer Drugs Value Chain
  • Table Peptic Ulcer Drugs Distributors List
  • Table Peptic Ulcer Drugs Customers List
  • Table Global Peptic Ulcer Drugs Sales Forecast 2018-2025 (K Units) & (Million US$)
  • Figure Global Peptic Ulcer Drugs Sales Forecast 2018-2025 (K Units)
  • Figure Global Peptic Ulcer Drugs Revenue Forecast 2018-2025 (Million US$)
  • Table Global Peptic Ulcer Drugs Sales Forecast by Type 2018-2025 (K Units)
  • Figure Global Peptic Ulcer Drugs Sales Forecast by Type 2018-2025 (K Units)
  • Figure Global Peptic Ulcer Drugs Sales Market Share Forecast by Type 2018-2025
  • Table Global Peptic Ulcer Drugs Sales Forecast by Application 2018-2025 (K Units)
  • Figure Global Peptic Ulcer Drugs Sales Forecast by Application 2018-2025 (K Units)
  • Figure Global Peptic Ulcer Drugs Sales Market Share Forecast by Application 2018-2025
  • Table Global Peptic Ulcer Drugs Sales Forecast by Regions 2018-2025 (K Units)
  • Figure Global Peptic Ulcer Drugs Sales Forecast by Regions 2018-2025 (K Units)
  • Figure Global Peptic Ulcer Drugs Sales Market Share Forecast by Regions 2018-2025
  • Table Global Peptic Ulcer Drugs Revenue Forecast by Regions 2018-2025 (Million US$)
  • Figure Global Peptic Ulcer Drugs Revenue Forecast by Regions 2018-2025 (Million US$)
  • Figure Global Peptic Ulcer Drugs Revenue Market Share Forecast by Regions 2018-2025
  • Table North America Peptic Ulcer Drugs Sales Forecast by Countries 2018-2025 (K Units)
  • Table North America Peptic Ulcer Drugs Sales Market Share Forecast by Countries 2018-2025
  • Table North America Peptic Ulcer Drugs Revenue Forecast by Countries 2018-2025 (Million US$)
  • Table North America Peptic Ulcer Drugs Revenue Market Share Forecast by Countries 2018-2025
  • Figure United States Peptic Ulcer Drugs Sales Forecast 2018-2025 (K Units)
  • Figure Canada Peptic Ulcer Drugs Sales Forecast 2018-2025 (K Units)
  • Figure MexicoPeptic Ulcer Drugs Sales Forecast 2018-2025 (K Units)
  • Table Europe Peptic Ulcer Drugs Sales Forecast by Countries 2018-2025 (K Units)
  • Table Europe Peptic Ulcer Drugs Sales Market Share Forecast by Countries 2018-2025
  • Table Europe Peptic Ulcer Drugs Revenue Forecast by Countries 2018-2025 (Million US$)
  • Table Europe Peptic Ulcer Drugs Revenue Market Share Forecast by Countries 2018-2025
  • Figure Germany Peptic Ulcer Drugs Sales Forecast 2018-2025 (K Units)
  • Figure France Peptic Ulcer Drugs Sales Forecast 2018-2025 (K Units)
  • Figure UK Peptic Ulcer Drugs Sales Forecast 2018-2025 (K Units)
  • Figure Italy Peptic Ulcer Drugs Sales Forecast 2018-2025 (K Units)
  • Figure Russia Peptic Ulcer Drugs Sales Forecast 2018-2025 (K Units)
  • Table Asia Pacific Peptic Ulcer Drugs Sales Forecast by Countries 2018-2025 (K Units)
  • Table Asia Pacific Peptic Ulcer Drugs Sales Market Share Forecast by Countries 2018-2025
  • Table Asia Pacific Peptic Ulcer Drugs Revenue Forecast by Countries 2018-2025 (Million US$)
  • Table Asia Pacific Peptic Ulcer Drugs Revenue Market Share Forecast by Countries 2018-2025
  • Figure China Peptic Ulcer Drugs Sales Forecast 2018-2025 (K Units)
  • Figure Japan Peptic Ulcer Drugs Sales Forecast 2018-2025 (K Units)
  • Figure Korea Peptic Ulcer Drugs Sales Forecast 2018-2025 (K Units)
  • Figure India Peptic Ulcer Drugs Sales Forecast 2018-2025 (K Units)
  • Figure Australia Peptic Ulcer Drugs Sales Forecast 2018-2025 (K Units)
  • Figure Indonesia Peptic Ulcer Drugs Sales Forecast 2018-2025 (K Units)
  • Figure Thailand Peptic Ulcer Drugs Sales Forecast 2018-2025 (K Units)
  • Figure Malaysia Peptic Ulcer Drugs Sales Forecast 2018-2025 (K Units)
  • Figure Philippines Peptic Ulcer Drugs Sales Forecast 2018-2025 (K Units)
  • Figure Vietnam Peptic Ulcer Drugs Sales Forecast 2018-2025 (K Units)
  • Table Central & South America Peptic Ulcer Drugs Sales Forecast by Countries 2018-2025 (K Units)
  • Table Central & South America Peptic Ulcer Drugs Sales Market Share Forecast by Countries 2018-2025
  • Table Central & South America Peptic Ulcer Drugs Revenue Forecast by Countries 2018-2025 (Million US$)
  • Table Central & South America Peptic Ulcer Drugs Revenue Market Share Forecast by Countries 2018-2025
  • Figure Brazil Peptic Ulcer Drugs Sales Forecast 2018-2025 (K Units)
  • Table Middle East and Africa Peptic Ulcer Drugs Sales Forecast by Regions 2018-2025 (K Units)
  • Table Middle East and Africa Peptic Ulcer Drugs Sales Market Share Forecast by Regions 2018-2025
  • Table Middle East and Africa Peptic Ulcer Drugs Revenue Forecast by Regions 2018-2025 (Million US$)
  • Table Middle East and Africa Peptic Ulcer Drugs Revenue Market Share Forecast by Regions 2018-2025
  • Figure GCC Countries Peptic Ulcer Drugs Sales Growth Rate (2016-2025) (K Units)
  • Figure Egypt Peptic Ulcer Drugs Sales Growth Rate (2016-2025) (K Units)
  • Figure South Africa Peptic Ulcer Drugs Sales Growth Rate (2016-2025) (K Units)
  • Table Research Programs/Design for This Report
  • Figure Bottom-up and Top-down Approaches for This Report
目次

This study researches the market size of Peptic Ulcer Drugs, presents the global Peptic Ulcer Drugs sales and revenue by companies, regions, type and application, history breakdown data from 2013 to 2018, and forecast to 2025.

This report focuses on the key data information of Peptic Ulcer Drugs in key regions like North America, Europe, Asia Pacific, Central & South America, and Middle East & Africa, presents sales, revenue, market share, growth rate of Peptic Ulcer Drugs for each region and countries in each region.

For top companies, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2013 to 2018.

This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

Drug treatment of peptic ulcers is targeted at either counteracting aggressive factors or stimulating the mucosal defense.

Drugs that inhibit or neutralize gastric acid secretion include histamine H2-receptor antagonists, proton pump inhibitors, anticholinergics, prostaglandins and antacids.

In 2018, the global Peptic Ulcer Drugs market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Peptic Ulcer Drugs.

This report includes the following manufacturers; we can also add the other companies as you want.

  • Daewoong Pharmaceutical
  • Takeda Pharmaceutical
  • Pfizer
  • Abbott Laboratories
  • AstraZeneca
  • Cadila Healthcare
  • Boehringer Ingelheim
  • Eisai
  • Yuhan
  • GlaxoSmithKline Pharmaceuticals

Market Segment by Product Type

  • Proton Pump Inhibitors
  • Potassium-Competitive Acid Blockers
  • Antacids
  • H2-Antagonists
  • Antibiotics
  • Ulcer Protective Drugs

Market Segment by Application

  • Hospital Pharmacies
  • Private Clinics
  • Drug Stores
  • Retail Pharmacies
  • E-Commerce

Market size split by Region

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Indonesia
    • Malaysia
    • Philippines
    • Thailand
    • Vietnam
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Central & South America
    • Brazil
    • Rest of Central & South America
  • Middle East & Africa
    • GCC Countries
    • Egypt
    • South Africa

The study objectives are:

  • To analyze and research the global Peptic Ulcer Drugs status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
  • To present the key Peptic Ulcer Drugs manufacturers, capacity, production, revenue, market share, and recent development for key players.
  • To split the breakdown data by regions, type, companies and applications.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends, drivers, influence factors in global and regions.
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Peptic Ulcer Drugs are as follows:

  • History Year: 2013-2018
  • Base Year: 2017
  • Estimated Year: 2018
  • Forecast Year 2018 to 2025

Table of Contents

1 Report Overview

  • 1.1 Research Scope
  • 1.2 Major Manufacturers Covered in This Report
  • 1.3 Market Segment by Type
    • 1.3.1 Global Peptic Ulcer Drugs Market Size Growth Rate by Type
    • 1.3.2 Proton Pump Inhibitors
    • 1.3.3 Potassium-Competitive Acid Blockers
    • 1.3.4 Antacids
  • 1.4 Market Segment by Application
    • 1.4.1 Global Peptic Ulcer Drugs Market Share by Application (2018-2025)
    • 1.4.2 Hospital Pharmacies
    • 1.4.3 Private Clinics
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Growth Trends

  • 2.1 Global Peptic Ulcer Drugs Market Size
    • 2.1.1 Global Peptic Ulcer Drugs Revenue 2013-2025
    • 2.1.2 Global Peptic Ulcer Drugs Sales 2013-2025
  • 2.2 Peptic Ulcer Drugs Growth Rate by Regions
    • 2.2.1 Global Peptic Ulcer Drugs Sales by Regions 2013-2018
    • 2.2.2 Global Peptic Ulcer Drugs Revenue by Regions 2013-2018
  • 2.3 Industry Trends
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers

3 Market Share by Manufacturers

  • 3.1 Peptic Ulcer Drugs Sales by Manufacturers
    • 3.1.1 Peptic Ulcer Drugs Sales by Manufacturers 2013-2018
    • 3.1.2 Peptic Ulcer Drugs Sales Market Share by Manufacturers 2013-2018
  • 3.2 Revenue by Manufacturers
    • 3.2.1 Peptic Ulcer Drugs Revenue by Manufacturers (2013-2018)
    • 3.2.2 Peptic Ulcer Drugs Revenue Share by Manufacturers (2013-2018)
    • 3.2.3 Global Peptic Ulcer Drugs Market Concentration Ratio (CR5 and HHI)
  • 3.3 Peptic Ulcer Drugs Price by Manufacturers
  • 3.4 Key Manufacturers Peptic Ulcer Drugs Plants/Factories Distribution and Area Served
  • 3.5 Date of Key Manufacturers Enter into Peptic Ulcer Drugs Market
  • 3.6 Key Manufacturers Peptic Ulcer Drugs Product Offered
  • 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Sales and Revenue for Each Type
    • 4.1.1 Proton Pump Inhibitors Sales and Revenue (2013-2018)
    • 4.1.2 Potassium-Competitive Acid Blockers Sales and Revenue (2013-2018)
    • 4.1.3 Antacids Sales and Revenue (2013-2018)
  • 4.2 Global Peptic Ulcer Drugs Sales Market Share by Type
  • 4.3 Global Peptic Ulcer Drugs Revenue Market Share by Type
  • 4.4 Peptic Ulcer Drugs Price by Type

5 Market Size by Application

  • 5.1 Overview
  • 5.2 Global Peptic Ulcer Drugs Sales by Application

6 North America

  • 6.1 North America Peptic Ulcer Drugs Breakdown Data by Company
  • 6.2 North America Peptic Ulcer Drugs Breakdown Data by Type
  • 6.3 North America Peptic Ulcer Drugs Breakdown Data by Application
  • 6.4 North America Peptic Ulcer Drugs Breakdown Data by Countries
    • 6.4.1 North America Peptic Ulcer Drugs Sales by Countries
    • 6.4.2 North America Peptic Ulcer Drugs Revenue by Countries
    • 6.4.3 United States
    • 6.4.4 Canada
    • 6.4.5 Mexico

7 Europe

  • 7.1 Europe Peptic Ulcer Drugs Breakdown Data by Company
  • 7.2 Europe Peptic Ulcer Drugs Breakdown Data by Type
  • 7.3 Europe Peptic Ulcer Drugs Breakdown Data by Application
  • 7.4 Europe Peptic Ulcer Drugs Breakdown Data by Countries
    • 7.4.1 Europe Peptic Ulcer Drugs Sales by Countries
    • 7.4.2 Europe Peptic Ulcer Drugs Revenue by Countries
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 UK
    • 7.4.6 Italy
    • 7.4.7 Russia

8 Asia Pacific

  • 8.1 Asia Pacific Peptic Ulcer Drugs Breakdown Data by Company
  • 8.2 Asia Pacific Peptic Ulcer Drugs Breakdown Data by Type
  • 8.3 Asia Pacific Peptic Ulcer Drugs Breakdown Data by Application
  • 8.4 Asia Pacific Peptic Ulcer Drugs Breakdown Data by Countries
    • 8.4.1 Asia Pacific Peptic Ulcer Drugs Sales by Countries
    • 8.4.2 Asia Pacific Peptic Ulcer Drugs Revenue by Countries
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 Korea
    • 8.4.6 India
    • 8.4.7 Australia
    • 8.4.8 Indonesia
    • 8.4.9 Malaysia
    • 8.4.10 Philippines
    • 8.4.11 Thailand
    • 8.4.12 Vietnam

9 Central & South America

  • 9.1 Central & South America Peptic Ulcer Drugs Breakdown Data by Company
  • 9.2 Central & South America Peptic Ulcer Drugs Breakdown Data by Type
  • 9.3 Central & South America Peptic Ulcer Drugs Breakdown Data by Application
  • 9.4 Central & South America Peptic Ulcer Drugs Breakdown Data by Countries
    • 9.4.1 Central & South America Peptic Ulcer Drugs Sales by Countries
    • 9.4.2 Central & South America Peptic Ulcer Drugs Revenue by Countries
    • 9.4.3 Brazil

10 Middle East and Africa

  • 10.1 Middle East and Africa Peptic Ulcer Drugs Breakdown Data by Type
  • 10.2 Middle East and Africa Peptic Ulcer Drugs Breakdown Data by Application
  • 10.3 Middle East and Africa Peptic Ulcer Drugs Breakdown Data by Countries
    • 10.3.1 Middle East and Africa Peptic Ulcer Drugs Sales by Countries
    • 10.3.2 Middle East and Africa Peptic Ulcer Drugs Revenue by Countries
    • 10.3.3 GCC Countries
    • 10.3.4 Egypt
    • 10.3.5 South Africa

11 Company Profiles

  • 11.1 Daewoong Pharmaceutical
    • 11.1.1 Daewoong Pharmaceutical Company Details
    • 11.1.2 Company Description and Business Overview
    • 11.1.3 Sales, Revenue and Market Share of Peptic Ulcer Drugs
    • 11.1.4 Peptic Ulcer Drugs Product Introduction
    • 11.1.5 Daewoong Pharmaceutical Recent Development
  • 11.2 Takeda Pharmaceutical
    • 11.2.1 Takeda Pharmaceutical Company Details
    • 11.2.2 Company Description and Business Overview
    • 11.2.3 Sales, Revenue and Market Share of Peptic Ulcer Drugs
    • 11.2.4 Peptic Ulcer Drugs Product Introduction
    • 11.2.5 Takeda Pharmaceutical Recent Development
  • 11.3 Pfizer
    • 11.3.1 Pfizer Company Details
    • 11.3.2 Company Description and Business Overview
    • 11.3.3 Sales, Revenue and Market Share of Peptic Ulcer Drugs
    • 11.3.4 Peptic Ulcer Drugs Product Introduction
    • 11.3.5 Pfizer Recent Development
  • 11.4 Abbott Laboratories
    • 11.4.1 Abbott Laboratories Company Details
    • 11.4.2 Company Description and Business Overview
    • 11.4.3 Sales, Revenue and Market Share of Peptic Ulcer Drugs
    • 11.4.4 Peptic Ulcer Drugs Product Introduction
    • 11.4.5 Abbott Laboratories Recent Development
  • 11.5 AstraZeneca
    • 11.5.1 AstraZeneca Company Details
    • 11.5.2 Company Description and Business Overview
    • 11.5.3 Sales, Revenue and Market Share of Peptic Ulcer Drugs
    • 11.5.4 Peptic Ulcer Drugs Product Introduction
    • 11.5.5 AstraZeneca Recent Development
  • 11.6 Cadila Healthcare
    • 11.6.1 Cadila Healthcare Company Details
    • 11.6.2 Company Description and Business Overview
    • 11.6.3 Sales, Revenue and Market Share of Peptic Ulcer Drugs
    • 11.6.4 Peptic Ulcer Drugs Product Introduction
    • 11.6.5 Cadila Healthcare Recent Development
  • 11.7 Boehringer Ingelheim
    • 11.7.1 Boehringer Ingelheim Company Details
    • 11.7.2 Company Description and Business Overview
    • 11.7.3 Sales, Revenue and Market Share of Peptic Ulcer Drugs
    • 11.7.4 Peptic Ulcer Drugs Product Introduction
    • 11.7.5 Boehringer Ingelheim Recent Development
  • 11.8 Eisai
    • 11.8.1 Eisai Company Details
    • 11.8.2 Company Description and Business Overview
    • 11.8.3 Sales, Revenue and Market Share of Peptic Ulcer Drugs
    • 11.8.4 Peptic Ulcer Drugs Product Introduction
    • 11.8.5 Eisai Recent Development
  • 11.9 Yuhan
    • 11.9.1 Yuhan Company Details
    • 11.9.2 Company Description and Business Overview
    • 11.9.3 Sales, Revenue and Market Share of Peptic Ulcer Drugs
    • 11.9.4 Peptic Ulcer Drugs Product Introduction
    • 11.9.5 Yuhan Recent Development
  • 11.10 GlaxoSmithKline Pharmaceuticals
    • 11.10.1 GlaxoSmithKline Pharmaceuticals Company Details
    • 11.10.2 Company Description and Business Overview

12 Value Chain and Sales Channels Analysis

  • 12.1 Value Chain Analysis
  • 12.2 Sales Channels Analysis
    • 12.2.1 Peptic Ulcer Drugs Sales Channels
    • 12.2.2 Peptic Ulcer Drugs Distributors
  • 12.3 Peptic Ulcer Drugs Customers

13 Market Forecast

  • 13.1 Global Peptic Ulcer Drugs Sales and Revenue Forecast 2018-2025
  • 13.2 Global Peptic Ulcer Drugs Sales Forecast by Type
  • 13.3 Global Peptic Ulcer Drugs Sales Forecast by Application
  • 13.4 Peptic Ulcer Drugs Forecast by Regions
    • 13.4.1 Global Peptic Ulcer Drugs Sales Forecast by Regions 2018-2025
    • 13.4.2 Global Peptic Ulcer Drugs Revenue Forecast by Regions 2018-2025
  • 13.5 North America Market Forecast
    • 13.5.1 North America Peptic Ulcer Drugs Forecast by Countries 2018-2025
    • 13.5.2 United States
    • 13.5.3 Canada
    • 13.5.4 Mexico
  • 13.6 Europe Market Forecast
    • 13.6.1 Europe Peptic Ulcer Drugs Forecast by Countries 2018-2025
    • 13.6.2 Germany
    • 13.6.3 France
    • 13.6.4 UK
    • 13.6.5 Italy
    • 13.6.6 Russia
  • 13.7 Asia Pacific Market Forecast
    • 13.7.1 Asia Pacific Peptic Ulcer Drugs Sales Forecast by Countries 2018-2025
    • 13.7.2 China
    • 13.7.3 Japan
    • 13.7.4 Korea
    • 13.7.5 India
    • 13.7.6 Australia
    • 13.7.7 Indonesia
    • 13.7.8 Thailand
    • 13.7.9 Malaysia
    • 13.7.10 Philippines
    • 13.7.11 Vietnam
  • 13.8 Central & South America Market Forecast
    • 13.8.1 Central & South America Peptic Ulcer Drugs Sales Forecast by Countries 2018-2025
    • 13.8.2 Brazil
  • 13.9 Middle East and Africa Market Forecast
    • 13.9.1 Middle East and Africa Peptic Ulcer Drugs Sales Forecast by Countries 2018-2025
    • 13.9.2 GCC Countries
    • 13.9.3 Egypt
    • 13.9.4 South Africa

14 Research Findings and Conclusion

15 Appendix

  • 15.1 Research Methodology
    • 15.1.1 Methodology/Research Approach
      • 15.1.1.1 Research Programs/Design
      • 15.1.1.2 Market Size Estimation
      • 15.1.1.3 Market Breakdown and Data Triangulation
    • 15.1.2 Data Source
      • 15.1.2.1 Secondary Sources
      • 13.1.2.2 Primary Sources
  • 15.2 Author Details
  • 15.3 Disclaimer
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.